240 related articles for article (PubMed ID: 8486096)
21. Enhanced suppression of humoral immunity in DBA/2 mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Morris DL; Snyder NK; Gokani V; Blair RE; Holsapple MP
Toxicol Appl Pharmacol; 1992 Jan; 112(1):128-32. PubMed ID: 1310164
[TBL] [Abstract][Full Text] [Related]
22. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
23. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Tucker AN; Vore SJ; Luster MI
Mol Pharmacol; 1986 Apr; 29(4):372-7. PubMed ID: 3486342
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in B6C3F1 and DBA/2 mice following single and repeated exposures.
Morris DL; Jeong HG; Jordan SD; Kaminski NE; Holsapple MP
Arch Toxicol; 1998 Feb; 72(3):157-68. PubMed ID: 9520139
[TBL] [Abstract][Full Text] [Related]
25. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.
Wood SC; Jeong HG; Morris DL; Holsapple MP
Toxicology; 1993 Jul; 81(2):131-43. PubMed ID: 8378939
[TBL] [Abstract][Full Text] [Related]
26. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Doi H; Baba T; Tohyama C; Nohara K
Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
[TBL] [Abstract][Full Text] [Related]
27. Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Choi JY; Oughton JA; Kerkvliet NI
Int Immunopharmacol; 2003 Apr; 3(4):553-70. PubMed ID: 12689660
[TBL] [Abstract][Full Text] [Related]
28. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
29. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells.
Kerkvliet NI; Oughton JA
Toxicol Appl Pharmacol; 1993 Apr; 119(2):248-57. PubMed ID: 8480333
[TBL] [Abstract][Full Text] [Related]
30. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances antibody production and protein kinase activity in murine B cells.
Kramer CM; Johnson KW; Dooley RK; Holsapple MP
Biochem Biophys Res Commun; 1987 May; 145(1):25-33. PubMed ID: 3496088
[TBL] [Abstract][Full Text] [Related]
31. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to suppression of cytotoxic T cell generation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on the Ah genotype of the murine host.
Nagarkatti PS; Sweeney GD; Gauldie J; Clark DA
Toxicol Appl Pharmacol; 1984 Jan; 72(1):169-76. PubMed ID: 6608808
[TBL] [Abstract][Full Text] [Related]
33. CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis.
Prell RA; Dearstyne E; Steppan LG; Vella AT; Kerkvliet NI
Toxicol Appl Pharmacol; 2000 Aug; 166(3):214-21. PubMed ID: 10906285
[TBL] [Abstract][Full Text] [Related]
34. Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes.
McClure EA; North CM; Kaminski NE; Goodman JI
Toxicol Sci; 2011 Apr; 120(2):339-48. PubMed ID: 21212295
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
[TBL] [Abstract][Full Text] [Related]
36. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on interleukin-4-mediated mechanisms of immunity.
Karras JG; Conrad DH; Holsapple MP
Toxicol Lett; 1995 Jan; 75(1-3):225-33. PubMed ID: 7863531
[TBL] [Abstract][Full Text] [Related]
37. Search for the target genes involved in the suppression of antibody production by TCDD in C57BL/6 mice.
Nagai H; Takei T; Tohyama C; Kubo M; Abe R; Nohara K
Int Immunopharmacol; 2005 Feb; 5(2):331-43. PubMed ID: 15652763
[TBL] [Abstract][Full Text] [Related]
38. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.
Morris DL; Holsapple MP
Immunopharmacology; 1991; 21(3):171-81. PubMed ID: 1917439
[TBL] [Abstract][Full Text] [Related]
39. TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.
North CM; Kim BS; Snyder N; Crawford RB; Holsapple MP; Kaminski NE
Toxicol Sci; 2009 Jan; 107(1):85-92. PubMed ID: 18948302
[TBL] [Abstract][Full Text] [Related]
40. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules.
Vorderstrasse BA; Kerkvliet NI
Toxicol Appl Pharmacol; 2001 Mar; 171(2):117-25. PubMed ID: 11222087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
